Dual Monoclonal Antibodies on Sars-Cov-2 Alpha and Delta Variants: Clinical and Virological Efficacy

Monoclonal antibodies (MAbs) targeting the Spike glycoprotein of SARS-CoV-2 is a key strategy to prevent severe COVID-19. Here, the efficacy of two monoclonal antibody bitherapies against SARS-CoV-2 was assessed on 92 patients at high risk of severe COVID-19 between March and October 2021 (Bichat-Cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferré, Valentine Marie, Peiffer-Smadja, Nathan, Kramer, Laura, Coppée, Romain, Kante, Aïcha, Debarge, Margaux, Choquet, Christophe, Saint Joannis, Thibault, Bouzid, Donia, Messika, Jonathan, Le Grand, Jennifer, Thy, Michael, Kernéis, Solen, Descamps, Diane, Visseaux, Benoit, Ghosn, Jade
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Observation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603708/
https://www.ncbi.nlm.nih.gov/pubmed/36125289
http://dx.doi.org/10.1128/spectrum.02152-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603708/
https://www.ncbi.nlm.nih.gov/pubmed/36125289
http://dx.doi.org/10.1128/spectrum.02152-22

Ejemplares similares